Business
China Approves Merck's Covid-19 Antiviral Molnupiravir for Emergency Use as Beijing ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'China approves Merck’s Covid-19 antiviral molnupiravir for emergency use as Beijing seeks to expand access to treatments during a massive wave of infections ...'
China approves Merck’s Covid-19 antiviral molnupiravir for emergency use as Beijing seeks to expand access to treatments during a massive wave of infections https://t.co/piDTCmkISo— Bloomberg (@business) December 30, 2022
(The above story first appeared on LatestLY on Dec 30, 2022 03:01 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).